The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Mazerkina N.A.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko", Moskva

Trunin Yu.Yu.

Burdenko Neurosurgical Institute, Moscow, Russian Federation

Gorelyshev S.K.

GBU NII neĭrokhirurgii im. N.N. Burdenko

Golanov A.V.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Kadashev B.A.

NII neĭrokhirurgii im. N.N. Burdenko RAMN, Moskva

Shishkina L.V.

Burdenko Neurosurgery Institute, Moscow, Russia

Rotin D.A.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN

Karmanov M.E.

RDKB

Orlova E.M.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia Rossiĭskoĭ Federatsii, Moskva

Thyrotropin secreting pituitary adenoma in a child: case report and literature review

Authors:

Mazerkina N.A., Trunin Yu.Yu., Gorelyshev S.K., Golanov A.V., Kadashev B.A., Shishkina L.V., Rotin D.A., Karmanov M.E., Orlova E.M.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2012;76(5): 63‑69

Read: 2012 times


To cite this article:

Mazerkina NA, Trunin YuYu, Gorelyshev SK, et al. Thyrotropin secreting pituitary adenoma in a child: case report and literature review. Burdenko's Journal of Neurosurgery. 2012;76(5):63‑69. (In Russ.)

References:

  1. Beck-Peccoz P., Brucker-Davis F., Persani L., Smallridge R.C., Weintraub B.D. Thyrotropin-secreting pituitary tumors. Endocrin Rev 1996; 17: 610-638.
  2. Beck-Peccoz P., Persani L. Medical management of thyrotropin-secreting pituitary adenomas. Pituitary 2002; 5: 83-88.
  3. Beck-Peccoz P., Persani L. Thyrotropinomas. Endocrinol Metab Clin North Am 2008; 37: 8-9: 123-134.
  4. Beck-Peccoz P., Persani L. Variable biological activity of thyroid-stimulating hormone. Eur J Endocrinol 1994; 131: 331-340.
  5. Beckers A., Abs R., Mahler C., Vandalem J.L., Pirens G., Hennen G., Stevenaert A. Thyrotropin-secreting pituitary adenomas: report of seven cases. J Clin Endocrinol Metab 1991; 72: 477-483.
  6. Brucker-Davis F., Oldfield E.H., Skarulis M.C., Doppman J.L., Weintraub B.D. Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 1999; 84: 476-486.
  7. Chanson P., Orgiazzi J., Derome P.J., Bression D., Jedynak C.P., Trouillas J., Legentil P., Racadot J., Peillon F. Paradoxical response of thyrotropin to L-dopa and presence of dopaminergic receptors in a thyrotropin-secreting pituitary adenoma. J Clin Endocrinol Metab 1984; 59: 542-546.
  8. Chanson P., Weintraub B.D., Harris A.G. Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 1993; 119: 236-240.
  9. Ezzat S., Horvath E., Kovacs K., Smyth H.S., Singer W., Asa S.L. Basic Fibroblast Growth Factor Expression by Two Prolactin and Thyrotropin-Producing Pituitary Adenomas. Endocr Pathol 1995; 6: 125-134.
  10. Hall W.A., Luciano M.G., Doppman J.L., Patronas N.J., Oldfield E.H. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994; 120: 817-820.
  11. Kessler M., David R., Pawelczak M., Hanono A., Shah B. Thyrotropin-secreting pituitary adenoma in an adolescent boy: challenges in management. Pediatrics 2010; 126: e474-e478.
  12. Khandwala H., Lee C. Inappropriate secretion of thyroid-stimulating hormone. CMAJ 2006; 175: 351.
  13. Kienitz T., Quinkler M., Strasburger C.J., Ventz M. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature. Eur J Endocrinol 2007; 157: 39-46.
  14. Kuhn J.M., Arlot S., Lefebvre H., Caron P., Cortet-Rudelli C., Archambaud F., Chanson P., Tabarin A., Goth M.I., Blumberg J., Catus F., Ispas S., Beck-Peccoz P. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. J Clin Endocrinol Metab 2000; 85: 1487-1491.
  15. Nakayama Y., Jinguji S., Kumakura S.I., Nagasaki K., Natsumeda M., Yoneoka Y., Saito T., Fujii Y. Thyroid-stimulating hormone (thyrotropin)-secretion pituitary adenoma in an 8-year-old boy: case report. Pituitary.
  16. Ohki M., Sato K., Tuchiya D., Sato S., Saito S., Kinjo T., Kayama T., Jokura H., Yoshimoto T. A case of TSH-secreting pituitary adenoma associated with an unruptured aneurysm: successful treatment by two-stage operation and gamma-knife. No To Shinkei 1999; 51: 895-899.
  17. Refetoff S., Weiss R.E., Usala S.J. The syndromes of resistance to thyroid hormone. Endocrin Rev 1993; 14: 348-399.
  18. Shomali M.E., Katznelson L. Medical therapy for gonadotroph and thyrotroph tumors. Endocrinol Metab Clin North Am 1999; 28: 223-240, 8.
  19. Weiss R.E., Refetoff S. Resistance to thyroid hormone. Rev Endocr Metab Dis 2000; 1: 97-108.
  20. Yoshihara A., Isozaki O., Hizuka N., Nozoe Y., Harada C., Ono M., Kawamata T., Kubo O., Hori T., Takano K. Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapy. Endocr J 2007; 54: 133-138.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.